1. Home
  2. COO vs RGEN Comparison

COO vs RGEN Comparison

Compare COO & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Cooper Companies Inc.

COO

The Cooper Companies Inc.

HOLD

Current Price

$61.25

Market Cap

13.6B

Sector

Health Care

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$175.71

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COO
RGEN
Founded
1980
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.6B
11.0B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
COO
RGEN
Price
$61.25
$175.71
Analyst Decision
Hold
Buy
Analyst Count
17
22
Target Price
$65.80
★ $197.95
AVG Volume (30 Days)
★ 3.5M
1.2M
Earning Date
12-03-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 286.96
EPS
★ 2.49
0.24
Revenue
★ $2,532,800,000.00
$141,236,000.00
Revenue This Year
$3.58
$12.87
Revenue Next Year
$4.02
$29.67
P/E Ratio
★ $24.70
$738.08
Revenue Growth
18.41
★ 35.10
52 Week Low
$51.01
$100.99
52 Week High
$89.83
$198.87

Technical Indicators

Market Signals
Indicator
COO
RGEN
Relative Strength Index (RSI) 61.27 48.53
Support Level $59.02 $158.62
Resistance Level $63.32 $187.36
Average True Range (ATR) 1.38 8.73
MACD 1.08 -0.36
Stochastic Oscillator 93.96 49.63

Price Performance

Historical Comparison
COO
RGEN

About COO The Cooper Companies Inc.

CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: